Veriheal

AUGUST 31, 2021

We are honored to present the 20 winners of Veriheal’s Innovation in Cannabis Scholarship 2021. Veriheal’s Innovation in Cannabis Scholarship 2021 Winners . The app would also provide data to producers and distributors to identify trends in the market to better serve the needs of consumers. . Matthew Aaron Vogel .

Research and Development 116

Research and Development Supply Chain Programs Education 116

Cannabis Law Report

AUGUST 23, 2022

Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy. It’s a very significant case,” Melewsky told Spotlight PA. “And

Data 52

Data Treatment Patients Chronic Pain 52

Cannabis Law Report

NOVEMBER 29, 2021

State legislators in 2021 enacted over 50 laws liberalizing marijuana policies in more than 25 states, according to a report issued today by the National Organization of the Reform of Marijuana Laws (NORML). 2021 was a significant year for marijuana policy reform. The law took effect on July 1, 2021. FULL REPORT. New Jersey.

Legislation 98

Legislation Patients Retail Access 98

Cannabis Law Report

AUGUST 10, 2021

Enters into the Chronic Pain Market with Psychedelics. CSE: LOAN ) (FSE: O3X) (OTCQB: PNNRF) (formerly Redfund Capital Corp.) (“Global” or the “Company”) is pleased to announce the signing of a definitive agreement on August 6th 2021 memorializing the Global Wellness Strategies , Inc. 2 Pain 1994 Apr;57(1):5-15.

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. 1, 2020, and July 31, 2021—a 43% increase from the same period a year before. For too long, America has relied too heavily on opioids for pain relief. The Opioid Problem.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Watch how Supera-CBD works. “We

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

JUNE 1, 2021

TORONTO, June 01, 2021 (GLOBE NEWSWIRE) — via InvestorWire – RYAH Group, Inc. The 5-year study is expected to cover tens of thousands of patients suffering from chronic pain, which makes it one of the largest and most ambitious research projects to be conducted in the plant-based treatment arena. About RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Healer

MARCH 26, 2021

March 19, 2021. For years, Tim Gresh took dozens of prescription opioid medications per day, seeking any relief for the debilitating back pain that he – no matter which medication or therapy he used – could just not shake. . Others aren’t so sure. This article was originally published in the Portland Press Herald.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Healer

MARCH 26, 2021

Read the full story, Medical Cannabis Studies Ramp Up, Offering Hope to Some Opioid Users, which reports on Maine Resident Tim Gresh who is one of an increasing number of patients who swear by medical cannabis not only as a therapy option for chronic pain, but also as a pain management alternative to conventional opiates.

Chronic Pain 52

Chronic Pain Therapy Data Patients 52

Healer

MARCH 26, 2021

Read the full story, Medical Cannabis Studies Ramp Up, Offering Hope to Some Opioid Users, which reports on Maine Resident Tim Gresh who is one of an increasing number of patients who swear by medical cannabis not only as a therapy option for chronic pain, but also as a pain management alternative to conventional opiates.

Chronic Pain 52

Chronic Pain Therapy Data Patients 52

Healer

MARCH 26, 2021

Read the full story, Medical Cannabis Studies Ramp Up, Offering Hope to Some Opioid Users, which reports on Maine Resident Tim Gresh who is one of an increasing number of patients who swear by medical cannabis not only as a therapy option for chronic pain, but also as a pain management alternative to conventional opiates.

Chronic Pain 52

Chronic Pain Therapy Data Patients 52

Cannabis Law Report

NOVEMBER 15, 2021

Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the three and nine months ended September 30, 2021, and other recent developments. “We Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

JUNE 24, 2021

DUBLIN–(BUSINESS WIRE)–The “Global Cannabidiol Market (2021-2026) by Source, Distribution Channel, Product, Route of Administration, End-user, Geography, Competitive Analysis and the Impact of COVID-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. Why buy this report?

Research and Development 78

Research and Development Tincture Chronic Pain Pharmaceutical 78

Cannabis Law Report

NOVEMBER 2, 2021

NORML is pleased to announce that its newly updated and revised publication, Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature, 2000 — 2021 , is now available for download on the Kindle app. Proceeds from the purchase of the new book directly fund NORML’s cannabis advocacy efforts.

Safety 52

Safety Patients Chronic Pain Advocacy 52

Cannabis Law Report

SEPTEMBER 13, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. 3 Nature Aging | VOL 1 | July 2021 | p. Chief Scientific Officer.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Canna Care Docs

DECEMBER 16, 2020

The New Year is fast approaching, and if you’re not feeling entirely hopeful about 2021, you’re certainly not alone. Could medical cannabis help you find the “new you” in 2021? Chronic pain. One of the most widespread uses of medical marijuana is for chronic pain. Enough is enough. Multiple sclerosis.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Cannabis Law Report

AUGUST 24, 2022

The third Cannabis as Medicine Survey (CAMS20) follows on from CAMS16 and CAMS18, and includes 1,600 people using medical cannabis between September 2020 and January 2021. The results were recently published in Harm Reduction Journal. percent of respondents reporting prescription use in the 2018 iteration of the CAMS survey (CAMS18).

Medicine 52

Medicine Legalization Chronic Pain Access 52

Cannabis Law Report

OCTOBER 1, 2021

Mack will present an overview of Virpax and take part in a fireside chat moderated by Noble Capital Markets senior equity research analyst, Gregory Aurand at the Pain Management Virtual Investor Forum on Thursday, October 7, 2021 at 9:00 a.m. Eastern time. www.youtube.com/channelchek. About Virpax Pharmaceuticals. About Channelchek.

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Chronic Pain 52

Cannabis Law Report

JULY 20, 2021

While states across the country consider how best to address the mental health and opioid crisis facing our nation, psychedelic medicines are being extensively researched and reported as being a game-changing therapy for PTSD, suicide, chronic pain, and other illnesses. Eric Rahn, Managing Director.

Medicine 98

Medicine Business Research and Development Chronic Pain 98

Cannabis Law Report

DECEMBER 11, 2021

The clinic established the UK Medical Cannabis Registry to offer patients medical cannabis products at a reduced price while collecting and analysing clinical data from real-world evidence “to expand our understanding of medical cannabis in the UK”. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

NOVEMBER 10, 2021

The NIH has also engaged a firm to manufacture Leu-enkephalin (L-ENK), the active ingredient in Envelta and a firm to manufacture the Molecular Envelope Technology (MET) that is used to carry the L-ENK to the brain to promptly suppress pain. In October 2021, Virpax announced that a $1.87 About Virpax Pharmaceuticals.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

TheAnswerPage

FEBRUARY 3, 2021

Currently and historically the most common qualifying condition reported by medical marijuana patients is chronic pain. In fact, according to an analysis by Boehnke et al, chronic pain was the qualifying condition reported by medical marijuana patients nearly 65 percent of the time (according to 2016 data).

Chronic Pain 16

Chronic Pain Conditions Data Patients 16

Veriheal

FEBRUARY 10, 2022

Data and storage options via the integrated Microsoft Azure platform. As of July 1, 2021, following a successful ballot initiative vote that occurred on Nov. Cancer associated with severe or chronic pain, nausea or severe vomiting, or cachexia or severe wasting. Med Card Registration via Cloud-based Registry.

Programs 52

Programs Chronic Pain Patients Conditions 52

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. Chronic pain. As of December 2021, medical cannabis legalization has been enacted across 37 U.S. by the year 2027 , at which point the market could be worth a staggering $33.2 Alzheimer’s.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

The Cannigma

JUNE 21, 2021

The study, available as an abstract in an online supplement of the journal Sleep , was due to be presented on Friday, June 11, at the annual meeting of the Associated Professional Sleep Societies, Virtual SLEEP 2021. Sleeping patterns a predictor for future cannabis and alcohol use. Shutterstock). Shutterstock).

Sleep 61

Sleep Data Patients Chronic Pain 61

The Cannigma

MARCH 2, 2021

The research team compiled the study by extracting archival data from Reddit’s open source application programming interface between 2008-2018. As of January, 2021, PTSD was by far the most-listed qualifying condition in the state, with 57,661 out of 107,371 patients.

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). Nov 24 2021.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

AUGUST 22, 2021

Patent Office between December 20, 2016 and June 29, 2021. Then, after no issued cannabis patents for a couple of years, 3 were issued in 2019; 9 were issued in 2020; and 13 have been issued so far in 2021. The data for the comparative study is in Table 2. 2021) | PAN2020. 2021) | OG Citron. What is Cannabis?

Sativa 105

Sativa Indica Hybrid Ruderalis 105

Healer

APRIL 5, 2021

Among animal research, it’s clear that CBD can reduce pain and inflammation in various models of pain, including neuropathic pain, inflammatory pain, and arthritis-related pain.[1] After treatment with CBD oil (max dose 75 mg twice daily), participants achieved significant reductions in pain.[4].

CBD 98

CBD Chronic Pain Oil Topical 98

The Cannigma

AUGUST 22, 2021

We were unable to find any research on THC tampons, although there is some data on suppositories. This potentially makes them more effective in directly treating 2 the source of pain in cases of menstrual cramps or endometriosis and should mean that fewer of the cannabinoids are lost in metabolization.

THC 119

THC CBD Research and Development Conditions 119

The Cannigma

JANUARY 13, 2023

The authors noted that while “promising data are emerging on the possible role of ECS in migraine…proper placebo-controlled trials are needed to establish a therapeutic role for cannabinoids.” 1 A 2008 study found serotonin and endocannabinoid levels, including anandamide, were lower in people with chronic migraines.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

DECEMBER 14, 2021

These new vaporizer pens complete Columbia Care’s initial medical product portfolio, which includes tinctures, launched in April 2020, and its proprietary solid-fill powder capsules, launched in April 2021, that remain unique in the UK market. In early 2021, the Company was the first to launch a solid-fill medical cannabis capsule in the UK.

Extraction 52

Extraction Patients Medicine Tincture 52

Cannabis Law Report

NOVEMBER 16, 2021

Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. Recruitment for the Phase 2 trial will begin immediately, and efficacy data is expected by the end of first quarter of 2022. “To 3 Nature Aging | VOL 1 | July 2021 | p. For more information, visit www.mymd.com.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

NOVEMBER 9, 2021

KWC has been operating profitably and expanding significantly with 2020 revenues in excess of USD$3.5MM, on track for USD$4.5MM in 2021. Transaction Highlights: This acquisition establishes Delic as the largest ecosystem of mental health clinics in the United States. Prior to this Transaction, KWC has grown without taking outside capital.

Treatment 52

Treatment Therapy Media Access 52

Veriheal

OCTOBER 5, 2020

Previously to now, the bill did not allow for the sale of cannabis edibles but as of the 1st of January 2021, the citizens of Hawaii will be able to purchase edibles from licensed medical cannabis dispensaries. . Hawaiians can get excited as the House Bill 2097 is set to take effect on the 1st of January 2021.

Edibles 52

Edibles Legalization Decriminalization Consumption 52

SpeedWeed

MARCH 6, 2021

Cannabis Voter Project (@Cannabis_Voter) March 3, 2021. Rodrigues re-introduced the measure in 2021, and it’s gaining some traction in Tallahassee. NORML (@NORML) March 4, 2021. That 90-day limit works out to 50mg per day per patient, which is not much for patients managing chronic pain or other conditions. .

THC 52

THC Patients Law Chronic Pain 52

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Data collection.

Research and Development 52

Research and Development Medicine Access Media 52